New Filings & Updated Terms (ending 9.27.19am)

NEW FILINGS

Company: ECMOHO Limited
Symbol: MOHO
Description: They are one of China’s leading integrated solution providers in the rapidly growing non-medical health and wellness market.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): UBS, CICC
Filed: 9-26-19
Listed Cash Raise: $150m

Company: BRP Group, Inc.
Symbol: BRP
Description: They are a rapidly growing independent insurance distribution firm delivering solutions that give our clients the peace of mind to pursue their purpose, passion and dreams.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): J.P. Morgan, BofA Merrill Lynch, Jefferies, Wells Fargo Securities
Co-Manager: Raymond James, Keefe Bruyette & Woods
Filed: 9-23-19
Listed Cash Raise: $100m

Company: BellRing Brands, Inc.
Symbol: BRBR
Description: They are a rapidly growing leader in the global convenient nutrition category, aiming to enhance the lives of our consumers by providing them with highly nutritious, great-tasting products they can enjoy throughout the day.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Morgan Stanley, Citigroup, J.P. Morgan, Goldman Sachs
Co-Manager: BofA Merrill Lynch, Barclays, BMO Capital Markets, Credit Suisse, Evercore ISI, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities, HSBC, Nomura, PNC Capital Markets, Rabo Securities, UBS Investment Bank
Filed: 9-20-19
Listed Cash Raise: $100m

Company: innate Pharma S.A.
Symbol: IPHA
Description: They are a biotechnology company focused on discovering, developing and commercializing first-in-class therapeutic antibodies designed to harness the immune system for the treatment of oncology indications with significant unmet medical need. Their ordinary shares are listed on Euronext Paris under the symbol “IPH.”
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Citigroup, SVB L:eerink, Evercore ISI
Filed: 9-20-19
Listed Cash Raise: $100m

TERMS ADDED

Company: MetroCity Bankshares Inc.
Symbol: MCBS
Description: They are MetroCity Bankshares, Inc., a bank holding company headquartered in the Atlanta metropolitan area. Their common stock is presently quoted on the OTC Market Group’s OTCQX Market under the symbol “MCBS.”
Shares: 1.939 million
Price Range: $14.50-$16.50
Market Cap: $370m-$420m
Trade Date: Thursday, 10/3
Underwriter(s): Keefe Bruyette & Woods, Raymond James
Co-manager(s): Hovde Group
Terms Added: 9-24-19

Company: BioNTech SE
Symbol: BNTX
Description: BioNTech was founded in 2008 on the understanding that every cancer patient’s tumor is unique and that in order to effectively address this challenge, we must create individualized treatments for each patient.
Shares: 13.2 million ADSs
Price Range: $18.00-$20.00
Market Cap: $4.1b-$4.6b
Trade Date: Thursday, 10/10
Underwriter(s): JP Morgan, BofA Merrill Lynch, UBS Investment Bank, SVB Leerink
Co-Manager: Canaccord Genuity, Bryan Garnier & Co., Berenberg, Wolfe Capital Markets, Kempen, Mirae Asset Securities
Terms Added: 9-24-19

Company: Frequency Therapeutics, Inc.
Symbol: FREQ
Description: They are a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases.
Shares: 6.7 million
Price Range: $14.00-$16.00
Market Cap: $436m-$500m
Trade Date: Thursday, 10/3
Underwriter(s): J.P. Morgan, Goldman Sachs, Cowen
Terms Added: 9-23-19

Company: ADC Therapeutics SA
Symbol: ADCT
Description: They are a clinical-stage oncology-focused biotechnology company pioneering the development of highly potent and targeted antibody drug conjugates for patients suffering from hematological malignancies and solid tumors.
Shares: 8.164 million
Price Range: $23.00-$26.00
Market Cap: $1.7b-$1.9b
Trade Date: Thursday, 10/3
Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Cowen
Terms Added: 9-23-19

Company: Aprea Therapeutics Inc.
Symbol: APRE
Description: They are a clinical-stage biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. p53 is the protein expressed from the TP53 gene, the most commonly mutated gene in cancer.
Shares: 5 million
Price Range: $14.00-$16.00
Market Cap: $270m-$310m
Trade Date: Thursday, 10/3
Underwriter(s): JP Morgan, Morgan Stanley, RBC Capital
Terms Added: 9-23-19

Company: Viela Bio, Inc.
Symbol: VIE
Description: They are a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, which we collectively refer to as autoimmune diseases.
Shares: 7.5 million
Price Range: $19.00-$21.00
Market Cap: $940m-$1.03b
Trade Date: Thursday, 10/3
Underwriter(s): Goldman Sachs, Morgan Stanley, Cowen
Co-manager(s): Guggenheim
Terms Added: 9-23-19